minigastrin

Known as: gastrin-14, SHG14NS, gastrin (21-34) 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1974-2017
051019742017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
PURPOSE A variety of tumors in different organs with good accessibility to near-infrared light express the cholecystokinin-2 (CCK… (More)
Is this relevant?
2009
2009
Two cyclized minigastrin analogues for gastrin receptor scintigraphy were synthesized and derivatized with HYNIC at the N… (More)
Is this relevant?
2007
2007
INTRODUCTION During therapy with radiolabeled peptides, the kidney is most often the critical organ. Newly developed peptides are… (More)
Is this relevant?
2005
2005
UNLABELLED Uptake of radiolabeled peptides in the kidneys may obscure abdominal tumors in radiopeptide scintigraphy. This problem… (More)
Is this relevant?
2004
2004
Gastrin/CCK-2 receptors are overexpressed in a number of tumors such as medullary thyroid cancer (MTC) and small cell lung cancer… (More)
Is this relevant?
2004
2004
UNLABELLED Routine application of (18)F-labeled peptides for quantitative in vivo receptor imaging of receptor-expressing tissues… (More)
Is this relevant?
2003
2003
The development of monofunctional DTPA derivatives has been a major breakthrough in the labelling of proteins or peptides with a… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
1979
1979
Evidence is presented that minigastrin is the C-terminal tetradecapeptide amide of gastrin and not the tridecapeptide amide as… (More)
Is this relevant?
1979
1979
The secretory potency and disappearance rates of pure synthetic human non-sulphated minigastrin (HG-14-I) and pure natural human… (More)
  • figure 2
Is this relevant?
1974
1974
Minigastrin, a gastrin with 13 amino-acid residues, was recently isolated from tissues by Gregory and Tracy (1974). In this study… (More)
  • figure 1
  • table I
  • table II
  • figure 2
Is this relevant?